Dan E. Sturdevant

1.5k total citations
18 papers, 910 citations indexed

About

Dan E. Sturdevant is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Dan E. Sturdevant has authored 18 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Dan E. Sturdevant's work include Liver Disease Diagnosis and Treatment (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Hepatitis C virus research (3 papers). Dan E. Sturdevant is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Hepatitis C virus research (3 papers). Dan E. Sturdevant collaborates with scholars based in United States, United Kingdom and Japan. Dan E. Sturdevant's co-authors include Stephen F. Porcella, Kimmo Virtaneva, John G. McHutchison, Henry Masur, Eric G. Meissner, Wanhu Tang, Ulrich Siebenlist, Sun Saret, Søren Ulrik Sønder and Anu Osinusi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Dan E. Sturdevant

17 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan E. Sturdevant United States 12 317 299 287 280 122 18 910
Marcello Merola Italy 19 298 0.9× 218 0.7× 132 0.5× 271 1.0× 32 0.3× 44 812
Congwen Wei China 19 616 1.9× 554 1.9× 145 0.5× 320 1.1× 113 0.9× 36 1.2k
Malika Ait‐Goughoulte France 17 169 0.5× 217 0.7× 655 2.3× 788 2.8× 63 0.5× 25 1.1k
Yinghui Shi China 10 180 0.6× 200 0.7× 120 0.4× 151 0.5× 37 0.3× 19 625
Laura Arribillaga Spain 14 163 0.5× 516 1.7× 204 0.7× 188 0.7× 64 0.5× 22 819
Marie-Anne Petit France 18 198 0.6× 135 0.5× 589 2.1× 612 2.2× 39 0.3× 35 968
Annemarie Lekkerkerker United States 14 232 0.7× 298 1.0× 48 0.2× 130 0.5× 72 0.6× 25 759
Kara Carter United States 10 222 0.7× 189 0.6× 54 0.2× 237 0.8× 64 0.5× 17 670
Peter H. McGuinness Australia 8 257 0.8× 88 0.3× 207 0.7× 244 0.9× 39 0.3× 8 693
Michelle J. Farquhar United Kingdom 18 325 1.0× 140 0.5× 1.0k 3.5× 906 3.2× 78 0.6× 33 1.5k

Countries citing papers authored by Dan E. Sturdevant

Since Specialization
Citations

This map shows the geographic impact of Dan E. Sturdevant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan E. Sturdevant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan E. Sturdevant more than expected).

Fields of papers citing papers by Dan E. Sturdevant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan E. Sturdevant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan E. Sturdevant. The network helps show where Dan E. Sturdevant may publish in the future.

Co-authorship network of co-authors of Dan E. Sturdevant

This figure shows the co-authorship network connecting the top 25 collaborators of Dan E. Sturdevant. A scholar is included among the top collaborators of Dan E. Sturdevant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan E. Sturdevant. Dan E. Sturdevant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Aistleitner, Karin, Tina R. Clark, Dan E. Sturdevant, et al.. (2023). Identification of an autotransporter peptidase of Rickettsia rickettsii responsible for maturation of surface exposed autotransporters. PLoS Pathogens. 19(7). e1011527–e1011527. 4 indexed citations
2.
Mehedi, Masfique, Stacy Ricklefs, Ayato Takada, et al.. (2023). RNA Editing as a General Trait of Ebolaviruses. The Journal of Infectious Diseases. 228(Supplement_7). S498–S507. 1 indexed citations
3.
Holla, Prasida, Brian Dizon, Abhijit A. Ambegaonkar, et al.. (2021). Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity. Science Advances. 7(22). 83 indexed citations
4.
Kobayashi, Scott D., Adeline R. Porter, Sarah L. Anzick, Dan E. Sturdevant, & Frank R. DeLeo. (2019). Genome-Scale Transcript Analyses of Human Neutrophils. Methods in molecular biology. 277–298.
5.
Kumar, Krishan, P. Srinivasan, Michael Nold, et al.. (2017). Profiling invasive Plasmodium falciparum merozoites using an integrated omics approach. Scientific Reports. 7(1). 17146–17146. 9 indexed citations
6.
Faris, Robert, Roger A. Moore, Anne Ward, Dan E. Sturdevant, & Suzette A. Priola. (2017). Mitochondrial Respiration Is Impaired during Late-Stage Hamster Prion Infection. Journal of Virology. 91(18). 29 indexed citations
7.
Meissner, Eric G., Anita Kohli, Kimmo Virtaneva, et al.. (2016). Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis. Journal of Viral Hepatitis. 23(7). 496–505. 31 indexed citations
9.
Meissner, Eric G., Y.-J. Lee, Anu Osinusi, et al.. (2014). Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients. Hepatology. 61(3). 790–801. 118 indexed citations
10.
Moore, Roger A., Dan E. Sturdevant, Bruce Chesebro, & Suzette A. Priola. (2014). Proteomics Analysis of Amyloid and Nonamyloid Prion Disease Phenotypes Reveals Both Common and Divergent Mechanisms of Neuropathogenesis. Journal of Proteome Research. 13(11). 4620–4634. 18 indexed citations
11.
Meissner, Eric G., David Wu, Anu Osinusi, et al.. (2014). Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. Journal of Clinical Investigation. 124(8). 3352–3363. 155 indexed citations
12.
Kelada, Samir N. P., Praveen Sethupathy, Isobel Okoye, et al.. (2013). miR-182 and miR-10a Are Key Regulators of Treg Specialisation and Stability during Schistosome and Leishmania-associated Inflammation. PLoS Pathogens. 9(6). e1003451–e1003451. 91 indexed citations
13.
Sønder, Søren Ulrik, Sun Saret, Wanhu Tang, et al.. (2011). IL-17-induced NF-κB Activation via CIKS/Act1. Journal of Biological Chemistry. 286(15). 12881–12890. 119 indexed citations
14.
Greenberg, David E., Adam R. Shoffner, Adrian M. Zelazny, et al.. (2010). RecurrentGranulibacter bethesdensisInfections and Chronic Granulomatous Disease. Emerging infectious diseases. 16(9). 1341–1348. 30 indexed citations
15.
Wehrly, Tara D., Audrey Chong, Kimmo Virtaneva, et al.. (2009). Intracellular biology and virulence determinants ofFrancisella tularensisrevealed by transcriptional profiling inside macrophages. Cellular Microbiology. 11(7). 1128–1150. 141 indexed citations
16.
Voyich, Jovanka M., Dan E. Sturdevant, & Frank R. DeLeo. (2008). Analysis of Staphylococcus aureus Gene Expression During PMN Phagocytosis. Humana Press eBooks. 431. 109–122. 8 indexed citations
17.
Kobayashi, Scott D., Dan E. Sturdevant, & Frank R. DeLeo. (2007). Genome-Scale Transcript Analyses in Human Neutrophils. Methods in molecular biology. 2087. 441–453. 6 indexed citations
18.
Greenberg, David E., Stephen F. Porcella, Adrian M. Zelazny, et al.. (2007). Genome Sequence Analysis of the Emerging Human Pathogenic Acetic Acid Bacterium Granulibacter bethesdensis. Journal of Bacteriology. 189(23). 8727–8736. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026